Global Fertility Services Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2024 - 2034
Assisted reproduction services encompass a variety of methods and steps designed to support individuals and couples in achieving pregnancy starting from fertility evaluations and discussions to sophisticated treatments such as, in vitro fertilization (IVP) and intracytoplasmic sperm injection (ICSI).
Market Key Insights
- The Fertility Services market is projected to grow from $44.2 billion in 2024 to $93.6 billion in 2034. This represents a CAGR of 7.8%, reflecting rising demand across Assisted Reproductive Technology (ART) Services, Egg and Sperm Cryopreservation Services and Fertility Diagnostics Services.
Apollo Hospitals Enterprise Ltd., Care Fertility Group Ltd., Carolinas Fertility Institute are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Fertility Services market and are expected to observe the growth CAGR of 5.1% to 7.5% between 2024 and 2030.
- Emerging markets including India, Brazil and Mexico are expected to observe highest growth with CAGR ranging between 9.0% to 10.8%.
Transition like Upsurge in Assisted Reproductive Technology adoption is expected to add $7.1 billion to the Fertility Services market growth by 2030
- The Fertility Services market is set to add $49.4 billion between 2024 and 2034, with manufacturer targeting Fertility Clinics & Ambulatory Surgical Centers Service Provider projected to gain a larger market share.
- With Rising trend of delayed pregnancies, and Technological advancements in fertility procedures, Fertility Services market to expand 112% between 2024 and 2034.
Opportunities in the Fertility Services
Advancements in technology are pushing the limits of fertility treatment options forward. The development of apps for fertility tracking, mobile devices and home based diagnostic tools indicate a direction, for customized and convenient fertility care services.
Growth Opportunities in North America and Asia Pacific
North America Outlook
In the global fertility services market scene dominated by North America factors like heightened awareness about fertility treatments and advanced technology play a role along with the well established healthcare infrastructure in the region driving this dominance forward. Public and private investment, in health and wellness here has led to market growth. These key players are engaged in competition to solidify their positions by expanding service offerings and fostering innovation. Numerous business prospects await in the market with possibilities, for progress and the potential to offer customized treatment plans based on individual requirements.
Asia Pacific Outlook
In contrast the market for fertility services in the Asia Pacific region is expected to experience growth at a fast pace primarily due to the increasing number of infertility cases and greater adoption of advanced fertility treatments among people in developing nations such, as India and China.
Market Dynamics and Supply Chain
Driver: Rising trend of Delayed Pregnancies, and Increasing Prevalence of Infertility
The rise of cutting edge technologies in fertility solutions such as time lapse imaging of embryos and pre genetic testing before implantation is also driving the growth of the fertility services industry forward. The ongoing enhancements in technologies have also boosted the effectiveness of fertility treatments leading to a surge, in numbers and thereby fuel market expansion.
Restraint: High Cost of Treatment
Opportunity: Male Infertility An Underserved Market and IVF Tourism on the Rise
The trend of seeking fertility treatments across borders is gaining traction in the fertility services industry as couples are increasingly opting for cost top notch services overseas which has given rise to a profitable sector, in IVR tourism.
Challenge: Social Stigma and Cultural Barriers
Supply Chain Landscape
Labcorp Inc.
OPKO Health Inc
Merck & Co. Inc.
Ferring Pharmaceuticals
The Cooper Companies Inc.
Cook Medical LLC
Virtus Health
The US Fertility Network
Labcorp Inc.
OPKO Health Inc
Merck & Co. Inc.
Ferring Pharmaceuticals
The Cooper Companies Inc.
Cook Medical LLC
Virtus Health
The US Fertility Network
Applications of Fertility Services in Assisted Reproductive Technology (ART) , Egg & Sperm Cryopreservation & Diagnostics
ART is widely known as one of the applications in Fertility Services and includes procedures like in vitro fertilization (IVR) where eggs are fertilized outside the body and intracytoplasmic sperm injection (ICSI) that involves injecting a single sperm into an egg to overcome various infertility challenges faced by many couples and providing them with hope for starting a family. Supporters of these techniques include known names, like Reproductive Medicine Associates and Boston IVR.
Another important aspect of this field is the use of fertility testing services to help individuals or couples determine the underlying reasons for their fertility challenges. You can find a range of testing and assessment methods, in these services. The key benefit is the ability to pinpoint and tackle fertility issues. This increases the likelihood of treatment. Quest Diagnostics and Progenesis are leading providers offering fertility diagnostic services.
Freezing and storing eggs and sperm for fertility treatments is a common practice, in the field of assisted reproduction as well.
Recent Developments
Egg Bank Corporation broadened its reach by establishing five fertility centers in the Asia Pacific area as a response to the increasing need, in these developing markets.
ReproTech Ltd unveiled an AI powered technology aimed at enhancing the accuracy and effectiveness of in vitro fertilization procedures. This initiative reflects the growing emphasis, on incorporating technology into healthcare services.
Modern Fertility teamed up with Invitro Clinic in a partnership to offer tailored fertility solutions. This move aligns with the trend in the market, towards more personalized healthcare.